An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors
NCT04993261 · Status: ACTIVE_NOT_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 71
Last updated 2026-02-19
Summary
This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during routine CT scans to help obtain and process the image after the scan is complete. Doctors want to learn if dual energy computed tomography can help improve the detection of carcinoid tumors during routine CT scans.
Conditions
- Carcinoid Syndrome
- Carcinoid Tumor
- Digestive System Neuroendocrine Tumor G1
- Metastatic Carcinoid Tumor
Interventions
- PROCEDURE
-
Dual-Energy Computed Tomography
Undergo dual energy CT scan
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Ajaykumar Morani · M.D. Anderson Cancer Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-23
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
NCT00282906 ·Status: COMPLETED ·Phase: NA
-
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
NCT04152928 ·Status: UNKNOWN ·Phase: NA
-
Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms
NCT03288597 ·Status: UNKNOWN
-
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
NCT05709171 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors
NCT04804371 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
NCT03001349 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis
NCT00862680 ·Status: COMPLETED
-
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
NCT03403465 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study
NCT00907140 ·Status: COMPLETED ·Phase: NA
-
An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT05059717 ·Status: WITHDRAWN ·Phase: NA
-
MPDL3280A-imaging-IST-UMCG
NCT02453984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
NCT02174679 ·Status: NO_LONGER_AVAILABLE
-
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
NCT04219904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
NCT01967537 ·Status: COMPLETED ·Phase: PHASE2
-
Dual-Tracer Theranostic PET
NCT05680675 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
NCT00081094 ·Status: COMPLETED ·Phase: NA
-
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT06715839 ·Status: RECRUITING ·Phase: NA
-
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104 ·Status: UNKNOWN
-
SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors
NCT02840149 ·Status: COMPLETED ·Phase: PHASE3
-
Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial
NCT00316901 ·Status: COMPLETED ·Phase: PHASE2
-
DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis
NCT03685539 ·Status: COMPLETED ·Phase: NA
-
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
NCT05420558 ·Status: UNKNOWN
-
PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy
NCT01144897 ·Status: COMPLETED ·Phase: PHASE1
-
[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer
NCT05898854 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
NCT07132645 ·Status: RECRUITING ·Phase: EARLY_PHASE1